99 related articles for article (PubMed ID: 30711948)
21. Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
Park J; Song C; Shin E; Hong JH; Kim CS; Ahn H
Urol Oncol; 2013 Aug; 31(6):849-56. PubMed ID: 21782482
[TBL] [Abstract][Full Text] [Related]
22. Novel protein signatures suggest progression to muscular invasiveness in bladder cancer.
Berle M; Ghila L; Vethe H; Chaudhry A; Garberg H; Beisland C; Haaland ØA; Oveland E; Halvorsen OJ; Davidsson T; Chera S
PLoS One; 2018; 13(11):e0206475. PubMed ID: 30419021
[TBL] [Abstract][Full Text] [Related]
23. SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer.
Zhu F; Qian W; Zhang H; Liang Y; Wu M; Zhang Y; Zhang X; Gao Q; Li Y
Stem Cell Reports; 2017 Aug; 9(2):429-437. PubMed ID: 28793245
[TBL] [Abstract][Full Text] [Related]
24. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
Wu CT; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
[TBL] [Abstract][Full Text] [Related]
26. Tumor-associated Macrophages Facilitate Bladder Cancer Progression by Increasing Cell Growth, Migration, Invasion and Cytokine Expression.
Huang CP; Liu LX; Shyr CR
Anticancer Res; 2020 May; 40(5):2715-2724. PubMed ID: 32366417
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7.
Zhang J; Mao S; Wang L; Zhang W; Zhang Z; Guo Y; Wu Y; Yi F; Yao X
Oncol Rep; 2019 Feb; 41(2):819-828. PubMed ID: 30483807
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.
Yang C; Yuan W; Yang X; Li P; Wang J; Han J; Tao J; Li P; Yang H; Lv Q; Zhang W
Mol Cancer; 2018 Jan; 17(1):19. PubMed ID: 29386015
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological Profiling of LC3B, an Autophagy Marker, and ESRRA (Estrogen-related Receptor-alpha) in Muscle-invasive Bladder Cancer.
Kim S; Lee AJ; Yeo MK; Na YG; Kim JY; Cho MJ; Kim JS; Jo EK; Kim JM
Anticancer Res; 2018 Apr; 38(4):2429-2437. PubMed ID: 29599373
[TBL] [Abstract][Full Text] [Related]
31. miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.
Huang J; Wang B; Hui K; Zeng J; Fan J; Wang X; Hsieh JT; He D; Wu K
Oncol Rep; 2016 Sep; 36(3):1693-701. PubMed ID: 27430302
[TBL] [Abstract][Full Text] [Related]
32. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
[TBL] [Abstract][Full Text] [Related]
33. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
34. Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling.
Qian Y; Deng J; Xie H; Geng L; Zhou L; Wang Y; Yin S; Feng X; Zheng S
J Cancer Res Clin Oncol; 2009 Mar; 135(3):379-86. PubMed ID: 18825409
[TBL] [Abstract][Full Text] [Related]
35. Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder Cancer.
Kang HW; Seo SP; Byun YJ; Piao XM; Kim YH; Jeong P; Ha YS; Kim WT; Kim YJ; Lee SC; Moon SK; Choi YH; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2018 Aug; 16(4):274-280. PubMed ID: 29571585
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
[TBL] [Abstract][Full Text] [Related]
37. Bladder cancer outcome and subtype classification by gene expression.
Blaveri E; Simko JP; Korkola JE; Brewer JL; Baehner F; Mehta K; Devries S; Koppie T; Pejavar S; Carroll P; Waldman FM
Clin Cancer Res; 2005 Jun; 11(11):4044-55. PubMed ID: 15930339
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry Biomarkers in Nonmuscle Invasive Bladder Cancer.
Ranzi AD; da Silva JN; Graziottin TM; Annels N; Bica CG
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):178-183. PubMed ID: 26574637
[TBL] [Abstract][Full Text] [Related]
39. The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease.
Kim YW; Yun SJ; Jeong P; Kim SK; Kim SY; Yan C; Seo SP; Lee SK; Kim J; Kim WJ
PLoS One; 2015; 10(7):e0134552. PubMed ID: 26225770
[TBL] [Abstract][Full Text] [Related]
40. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
